Syne qua non (SQN), today announced a significant enhancement to their EDC and Clinical Trial Management System, Syne-clin®. A senior clinical research professional recently described Syne-clin®as delivering the ease of use and functionality that many envisaged EDC should have delivered when it was first introduced decades ago.
SQN have incorporated the wishes and feedback from many involved in clinical research, involving hundreds of clinical trials hosted in many countries. Rapid study start up coupled with innovative PDF based eCRFs with a paper look and feel, simplify the data collection process. Advanced real-time data validation and flexible drill down reporting through innovative project dashboards are additional reasons why the system is being received so positively across the industry.
One of the significant benefits of this new release is the ability to utilise new and emerging mobile technology. Tablet PCs and Smartphone devices enrich the PDF based eCRF collection experience. Multimedia, touch based interactive data entry screens, local language support, image management and helpful completion guidelines are provided as standard. Even in situations where the Internet is not available, secure 'offline' eCRF forms can collect data while retaining real-time data validation functionality, something that most EDC solutions cannot deliver. In addition, the solution offers hybrid paper and EDC data capture options. Syne-clin® meets prevailing regulatory guidelines including FDA 21 CFR Part 11 and has been audited recently by a leading regulatory agency as well as specialist QA/IT auditors from global pharma and biotech companies.
The new game changing functionality together with multimedia can be viewed at: www.synequanon.com . SQN would be happy to provide example eCRF templates for evaluation at no cost.
About Syne qua non (SQN)
SQN is a leading data management, statistical reporting and EDC specialist service provider and is recognised in helping its many customers to achieve their product development goals through innovative, quality based technology and processes, supported by an experienced team of professionals. SQN is a long-term trusted partner of many global pharma, biotech, medical device, consumer health and animal health focused companies as well as academic and health care providers.
Together with other specialist CRO partners, SQN also provides fully integrated clinical services capability supporting local or international trials where required.
Syne qua non (SQN)
Corporate and Media Inquiries: